Pleuropulmonary syndromes are conditions that affect the respiratory system, more specifically the pleura and lungs. There are different types of pleuropulmonary syndromes, such as pleurisy, pneumothorax, pleural effusion, and acute respiratory distress syndrome. These syndromes can be caused by a variety of factors, including infections, trauma, autoimmune diseases, or cancer. Treatment for pleuropulmonary syndromes varies depending on the cause and may include medication, surgical procedures, or respiratory physiotherapy. It is important to diagnose and treat these conditions early to prevent complications and improve patients' quality of life.
Learn about the main pulmonary syndromes that affect people's respiratory health.
Pleuropulmonary syndromes are conditions that directly affect the lungs and pleura, the membrane that lines the lungs and chest cavity. Several syndromes can compromise respiratory health, and it's important to understand the most common ones.
One of the most well-known pulmonary syndromes is pneumonia , which is a lung infection caused by bacteria, viruses, or fungi. Symptoms include fever, cough, chest pain, and shortness of breath. Treatment usually involves the use of antibiotics and rest.
Another common pleuropulmonary syndrome is asthma , a chronic condition that causes inflammation and narrowing of the airways, leading to breathing difficulties, wheezing, and coughing. Treatment includes the use of bronchodilators and corticosteroids.
Furthermore, pulmonary fibrosis is a syndrome characterized by the development of scarring in the lungs, which impairs the ability to breathe. Symptoms include shortness of breath, fatigue, and a dry cough. Treatment may involve the use of immunosuppressant medications and oxygen therapy.
It's important to emphasize that each pulmonary syndrome can have different causes, and a correct diagnosis is essential to ensure appropriate treatment. Consulting a pulmonology specialist is crucial to identify the syndrome and begin treatment as soon as possible.
Meaning of Pleuropulmonary: understand the term that refers to the lung and pleura.
The term pleuropulmonary refers to the relationship between the lungs and the pleura, the membrane that lines the lungs. When we talk about pleuropulmonary syndromes, we are referring to conditions that affect both the lungs and the pleura.
These syndromes can manifest in different ways, such as pleuritis, which is inflammation of the pleura, pneumonia, an infection in the lungs, or even pneumothorax, which is the accumulation of air between the pleura and the lungs.
The causes of pleuropulmonary syndromes can vary, from viral or bacterial infections to physical trauma or autoimmune diseases. Correct diagnosis is essential for effective treatment, which may include medication, physical therapy, or even surgery.
Therefore, understanding the meaning of pleuropulmonary is essential to understanding the conditions that affect the respiratory system and seeking the appropriate treatment for each case.
Diseases affecting the pleura: what are they and how do they manifest?
The pleura is a membrane that lines the lungs and chest wall, responsible for producing pleural fluid and lubricating the lungs during breathing. Several diseases can affect the pleura, causing symptoms such as chest pain, shortness of breath, and coughing.
One of the most common diseases affecting the pleura is pleurisy, which is inflammation of the pleural membrane. Pleurisy can be caused by viral, bacterial, or fungal infections, as well as other conditions such as pneumonia and pulmonary embolism. Symptoms of pleurisy include acute chest pain that worsens with breathing, a dry cough, and shortness of breath.
Another disease that affects the pleura is pleural effusion, which is the abnormal accumulation of fluid between the layers of the pleural membrane. Pleural effusion can be caused by infections, lung cancer, heart failure, and other conditions. Symptoms of pleural effusion include shortness of breath , cough with pinkish sputum, and chest pain.
Treatment for diseases affecting the pleura depends on the underlying cause. For pleurisy, treatment usually involves the use of analgesics and anti-inflammatories, in addition to treating the condition causing the inflammation. For pleural effusion, treatment may include draining the accumulated fluid and treating the underlying cause.
In short, diseases affecting the pleura, such as pleurisy and pleural effusion, can cause symptoms such as chest pain, shortness of breath, and coughing. Treatment for these diseases depends on the underlying cause and may involve medication, drainage of pleural fluid, and treatment of the underlying condition.
Learn about the different categories of pleural effusion.
There are several categories of pleural effusion, which can be classified according to their cause and characteristics. The main types of pleural effusion are exudate and transudate.
Exudative pleural effusion is characterized by being rich in proteins and cells, indicating an inflammatory process in the pleura. The most common causes of this type of effusion include infections, neoplasms, and autoimmune diseases.
Transudate pleural effusion is caused by an imbalance in hydrostatic and colloid osmotic pressures, leading to fluid accumulation in the pleural cavity. The main causes of this type of effusion include heart failure, liver cirrhosis, and nephrotic syndrome.
Furthermore, pleural effusions can also be classified as parapneumonic , when associated with lung infections, or malignant , when caused by neoplasms. Treatment of pleural effusions varies according to their cause, and may include the use of medications, pleural drainage, or even surgical procedures.
Pleuropulmonary syndromes: types, causes and treatments
Pleuro syndromes are a series of complex lower respiratory tract syndromes (between the main pulmonary alveoli and bronchi) that share two cardinal symptoms: cough and shortness of breath. Although the symptoms are similar, these syndromes have a distinct pathophysiology.
On the other hand, the cause of each syndrome complex is different, so clinical acuity is essential to establish a correct diagnosis. The pathophysiological event common to all pleuropulmonary syndromes is a decrease in the space available for gas exchange (ventilation) in the lung.
Similarly, fluid accumulation in the interstitial spaces is also a common pathophysiological event, interfering with normal respiratory dynamics. Although this is the common pathway responsible for the cardinal symptoms (cough and respiratory distress with or without hypoxemia), the pathway to achieve this varies depending on the type of syndrome.
Types, causes and treatments
Pleuropulmonary syndromes can be divided into 5 major groups:
– pulmonary condensation syndrome.
– atelectic syndrome.
– Pleural effusion.
– Pneumothorax.
– air trapping syndrome.
Each of them has different causes and characteristics, even when they share common symptoms. Similarly, treatment varies between one syndrome and another; hence the importance of early and accurate diagnosis, as failure to identify the cause can lead to serious complications.
Condensation lung syndrome
Lung condensation syndrome is referred to when there is a local or diffuse event that causes inflammation of the lung tissue.
This inflammation causes an increase in cell density in the affected lung region, in addition to the sequestration of fluids in the interstitial space.
The term “condensation” derives from the radiological finding (on chest x-rays) characterized by an increase in opacity in the affected area.
In other words, the tissue appears denser than the rest of the surrounding structures. Hence the term condensation. The patient typically presents with a cough, difficulty breathing, and fever.
Causes
– Lung tissue infections (pneumonia, tuberculosis, fungal infections).
– Pulmonary contusion (secondary to trauma).
– Lung cancer.
Treatment
Treatment for pulmonary condensation syndrome depends on the cause. When caused by infections, antimicrobials specific to the causative agent are usually required.
On the other hand, when the origin of the condensation is a bruise, rest is usually sufficient, unless the extent is such that surgery is necessary (something very rare).
In turn, lung cancer requires specific treatments including surgery, radiotherapy and, in some cases, chemotherapy.
Atelectatic syndrome
Atelectatic syndromes are all those conditions in which the lung alveoli collapse (close), allowing fluid to accumulate inside.
This increases the lung's dead space; that is, the amount of lung tissue that does not receive air, generating the classic symptoms of coughing and difficulty breathing.
Although on radiography it may be almost indistinguishable from a condensation syndrome, there are subtle signs (such as deviation of the trachea to the side of the pathological image on the x-ray) that guide this diagnosis.
From a pathophysiological point of view, the big difference is that condensation syndrome originates in the lung parenchyma (lung tissue), while atelectasis originates in obstructions at the level of the bronchi and bronchioles.
Causes
– Surfactant insufficiency (in full-term newborns).
– Obstruction of the respiratory tract from any cause (foreign bodies, scars, mucous membranes, tumors).
– Prolonged mechanical ventilation (due to surgery or hospitalization in the intensive care unit).
– Upper abdominal surgery (pain causes shallow breathing and, therefore, the alveoli at the base of the lung do not ventilate well, which ends up favoring the accumulation of fluid inside).
– Serious infections, such as lung abscess.
Treatment
Depending on the cause, appropriate treatment must be instituted, although there are common measures in all cases:
– Supplemental oxygen supply via cannula or mask (depending on the level of hypoxemia).
– Inspirations of encouragement (respiratory physiotherapy using the Triball equipment).
– Chest percussion.
At this point, it is important to emphasize that, although atelectasis can be treated, 90% of it can be prevented; hence the importance of respiratory physiotherapy and patient education before the event occurs, so that it can be avoided.
Pleural effusion
Pleural effusion is the accumulation of fluid in the pleural space, that is, between the chest wall and the lung. The severity of symptoms depends on the amount of fluid in the pleural space: the greater the amount, the more intense the symptoms, especially difficulty breathing.
Causes
Pleural effusions can be of two types: exudate and transudate. Exudates are usually caused by lung problems, typically lung cancer and complicated infections (pneumonia with pleural effusion or complicated tuberculosis).
In the case of transudates, the problem is usually extrapulmonary and may be due to a decrease in plasma oncotic pressure (hepatic failure, hypoproteinemia), an increase in pulmonary venous pressure (right heart failure), or water overload (renal failure).
Additionally, there is a third type of pleural effusion known as hemothorax. In these cases, it is neither a transudate nor an exudate, but blood.
The most common cause of hemothorax is chest trauma (penetration first and contusions second), although there may be cases of hemothorax without previous trauma, as in certain blood dyscrasias.
Treatment
Treatment of pleural effusion (described in some texts as hydrothorax) consists of evacuating the fluid from the pleural space, either by thoracentesis (thick needle puncture through the intercostal space) or by placing a chest tube attached to a closed drain (water trap).
In general, these measures should be taken urgently to alleviate the patient's respiratory distress, which is often severe. Once the situation is considered, the underlying cause should be corrected or at least controlled (whenever possible).
Pneumothorax
Pneumothorax is defined as the presence of air in the pleural cavity—that is, inside the chest but outside the lung. When this happens, air pressure begins to build up within the pleural space, preventing the lung from expanding normally and interfering with gas exchange.
In the first hours of evolution, pneumothorax is usually low pressure; therefore, symptoms are moderate (difficulty breathing and hypoxemia); however, as it progresses and more air accumulates in the pleural space, pressure increases, leading to a tension pneumothorax.
In these cases, the deterioration of respiratory function is severe and rapid, requiring urgent medical attention.
Causes
The most common cause of pneumothorax is penetrating chest trauma. In these cases, there is damage to the lung parenchyma, allowing air to escape into the pleural space.
However, trauma is not the only cause; in fact, there is a condition known as spontaneous pneumothorax in which air is present in the pleural space without any trauma.
The cause of this condition is the rupture of an emphysematous bullae (airbag) or subpleural bipae (small air bubbles).
Finally, pneumothorax can be a consequence of therapeutic procedures, such as barotrauma from mechanical ventilation, accidental puncture of the lung during procedures such as pleural biopsy and liver biopsy, placement of central venous accesses, among others.
Treatment
Treatment for pneumothorax involves evacuating the air that has accumulated in the pleural space. This usually involves placing a chest tube (also known as a thoracostomy catheter) connected to a sealed water-filled drain that allows air to escape but not re-enter.
Pneumothorax usually disappears within 2 to 5 days; however, if it persists, a specific procedure may be necessary, which may range from surgery (usually in cases of trauma) to pleurodesis.
Air trapping syndrome
This syndrome encompasses all diseases in which there are lung changes that prevent air from entering or leaving (chronic bronchitis) or leaving (pulmonary emphysema, bronchial asthma).
In all these cases, the lung tissue undergoes inflammatory and/or degenerative changes that prevent adequate gas exchange, generating the already known symptoms of coughing and difficulty breathing.
Causes
Air trap syndromes are mainly due to two causes:
– Chronic obstructive bronchopulmonary disease (CBOPD), which includes pulmonary emphysema and chronic bronchitis.
– Bronchial asthma.
There are other causes, such as alpha-1-antitrypsin deficiency, pneumonia, and cystic fibrosis, although all of these processes ultimately converge in the development of EBPOC, so they fall into this category.
Treatment
Treatment for air-trapping syndrome is specific to the cause. Thus, there are special treatments for asthma, and others for the management protocols for bronchitis and emphysema.
Although the medications may be the same in some cases, the doses, intervals between doses, and the combination of medications change depending on the cause.
It is very important to emphasize that all pleuropulmonary syndromes are delicate conditions that require specialized medical treatment; therefore, self-medication is never a good option.
On the other hand, pleuropulmonary syndromes can overlap or even lead to another, as in the case of pleural effusion that can cause atelectasis or atelectasis, which is secondarily infected by evolving into pneumonia (condensation syndrome).
For this reason, clinical surveillance is essential to avoid unpleasant surprises during the patient's evolution.
References
- Westerdahl, E., Lindmark, B., Eriksson, T., Hedenstierna, G. and Tenling, A. (2005). Deep breathing exercises reduce atelectasis and improve lung function after coronary artery bypass grafting.Chest , 128
- Bartlett, JG, Breiman, RF, Mandell, LA, & File Jr, TM (1998). Community-acquired pneumonia in adults: guidelines for management.Clinical infectious diseases , 26 (4), 811-838.Alà, JD (1990). Diving accidents (2). Respiratory barotrauma: pulmonary overpressure syndrome.Med Clin (Ship) , 95
- Talab, HF, Zabani, IA, Abdelrahman, HS, Bukhari, WL, Mamoun, I., Ashour, MA, … & El Sayed, SI (2009). Intraoperative ventilatory strategies for preventing pulmonary atelectasis in obese patients undergoing laparoscopic bariatric surgery.Anesthesia and Analgesia , 109
- Scientific Committee of SPauwels, R.A., Buist, A.S., Ma, P., Jenkins, C.R., Hurd, S.S., and GOLD. (2001) Global strategy for the diagnosis, treatment, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and the World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.Respiratory care , 46 (8), 798.
- Gobien, RP, Reines, HD, & Schabel, SI (1982). Localized tension pneumothorax: an unrecognized form of barotrauma in adult respiratory distress syndrome.Radiology , 142
- Donaldson, GC, Seemungal, TAR, Bhowmik, A. and Wedzicha, JA (2002). Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.Thorax , 57
- Flórez, AIA, Rojo, ACA, Fano, BL, López, AS and Velasco, MP Hydrothorax in Peritoneal Dialysis. About two cases.
- Symbas, PN, Justicz, AG, & Ricketts, RR (1992). Airway rupture due to blunt trauma: management of complex injuries.Annals of thoracic surgery , 54
- Laube, BL, Swift, DL, Wagner, JH, & Norman, PS (1986). The effect of bronchial obstruction on central airway deposition of a saline aerosol in patients with asthma.The American Review of Respiratory Diseases , 133
- Kiser, AC, O'brien, SM and Detterbeck, FC (2001). Blunt tracheobronchial injuries: treatment and outcomes.Annals of thoracic surgery , 71